It was shown that melatonin increases the cytotoxic effect of the chemotherapeutic agents, caspase-3 activation in CIS- and 5-FU-challenged cells and also elevated the ratio of the cells which enter mitochondrial apoptosis due to the production of reactive oxygen species. This evidence concerns the gene CASP3 and in situ carcinoma.